27 min
Screening: The Next Generation The Big Screen: How COVID-19 Disrupted and Reshaped Cancer Prevention
-
- Medicine
Cancer screening has saved countless lives through the early detection of breast, cervical, colorectal, and lung cancer. But there are still so many forms of cancer that slip through the cracks. Now, developments in medical research — such as multi-cancer screening blood tests and genomic tests — are promising to revolutionize cancer diagnostics.
In this episode, we talk to experts about the medical tech that is reshaping the field of early detection. Dr. Joseph Mikhael, Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute, talks about the importance of multi-cancer early detection tests and genomics in detecting cancers that we don't currently screen for. Dr. Brian Druker, Director of the Knight Cancer Institute at Oregon Health & Science University, talks about his role in spearheading the field of precision-based early cancer detection. And Jody Hoyos, President and Chief Operating Officer of Prevent Cancer Foundation, advocates for the passage of the Medicare Multi-Cancer Early Detection Screening Coverage Act to ensure equitable access to life-saving biotech.
The Big Screen is a product of OffScripHealth.
To learn more about rescheduling your cancer screening appointments, visit https://www.preventcancer.org/back-on-the-books/.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Cancer screening has saved countless lives through the early detection of breast, cervical, colorectal, and lung cancer. But there are still so many forms of cancer that slip through the cracks. Now, developments in medical research — such as multi-cancer screening blood tests and genomic tests — are promising to revolutionize cancer diagnostics.
In this episode, we talk to experts about the medical tech that is reshaping the field of early detection. Dr. Joseph Mikhael, Professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute, talks about the importance of multi-cancer early detection tests and genomics in detecting cancers that we don't currently screen for. Dr. Brian Druker, Director of the Knight Cancer Institute at Oregon Health & Science University, talks about his role in spearheading the field of precision-based early cancer detection. And Jody Hoyos, President and Chief Operating Officer of Prevent Cancer Foundation, advocates for the passage of the Medicare Multi-Cancer Early Detection Screening Coverage Act to ensure equitable access to life-saving biotech.
The Big Screen is a product of OffScripHealth.
To learn more about rescheduling your cancer screening appointments, visit https://www.preventcancer.org/back-on-the-books/.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
27 min